Skip to content

FRIV-4.INFO

Non è mai stato così facile cercare file popolari. Qui puoi trovare film e musica assolutamente gratuiti

TESI CARCINOMA CERVICE UTERINA SCARICARE


    Direttore: Prof: A.R Genazzani. Tesi di laurea: Il trattamento chemio-chirurgico nel carcinoma della cervice uterina in stadio localmente avanzato. Relatore. Questa tesi è inquadrata nella seconda parte dell'indagine ed è stata svolta . carcinoma invasivo a livello della cervice uterina (New England Journal of. I testi sono stati tradotti in italiano da un traduttore professionista e validati dalla . Vengono mostrati la vagina, l'utero, la cervice, le tube di Falloppio e le ovaie. TESI DI DOTTORATO Molecolare dei Carcinomi della Cervice Uterina Il Carcinoma della cervice uterina rappresenta un importante. Borra, Arianna () Conoscenze inerenti il tumore alla cervice uterina nelle giovani Il progetto di scrivere una tesi riguardante una problematica femminile .

    Nome: tesi carcinoma cervice uterina re
    Formato:Fichier D’archive
    Sistemi operativi: Android. iOS. MacOS. Windows XP/7/10.
    Licenza:Gratis!
    Dimensione del file:33.42 Megabytes

    Le url contenute in alcuni riferimenti sono raggiungibili cliccando sul link alla fine della citazione Vai! Il risultato dipende dalla formattazione della citazione. Classification of papillomaviruses. Specific interaction between HPV E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network.

    Papillomavirus E1 proteins: form, function, and features. Virus Genes. Role of the E1-E4 protein in the differentiation-dependent life cycle of human papillomavirus type J Virol.

    Fin qui appare tutto molto chiaro e ben definito. Queste ultime evidenziano i numerosi effetti benefici che le vaccinazioni possono offrire, trascurando ponderatamente le possibili reazioni inaspettate che esse potrebbero originare.

    Vi sono ancora dibattiti aperti riguardo all'efficacia e alla sicurezza dei vaccini rivolti a proteggere dall'infezione da HPV, e questo soprattutto perché il tumore alla cervice uterina si manifesta clinicamente anche dopo molti anni dal contagio virale.

    Abstract Nothing seems to upset us more than cancer,among all the diseases that plague us. Spite of the undeniable progress and reassuring scientific disclosure, cancer remains in the collective the black beast that we would like to keep away as much as possible.

    For this reason it is necessary to convince people to pay more attention to everything that concerns the safeguarding of health. The attention should therefore be extreme towards everything that allows the prevention of a disease, especially if it is a cancer disease.

    Thus, no wonder the relief with which it's received the news that, least for the cervical cancer, overlooks the promise of a new weapon: it is a vaccine.

    This time, however, the vaccine would not protect us against a "simple" disease, as it could be measles or rubella, but from a cancer that develops after many years about twenty from the age of viral infection.

    Conoscenze inerenti il tumore alla cervice uterina nelle giovani donne : un'indagine esplorativa

    However, it can not completely replace another method of prevention against cervical cancer, which is the Papanicolau test, better known as Pap-test, a test of cytological screening that allows to recognize the presence of abnormal cells and premalignant lesions caused by human Papillomavirus HPV , which hereafter could develop into a more serious disease.

    The combined use of these preventive methods has allowed a significant riduction of mortality by cervical cancer,that every year is the cause of high costs to public health, both in term of hospitalization, both for the treatment of it. Moreover, since are also available in Italy two Papillomavirus vaccines, Gardasil and Cervarix, as already mentioned, to accompany the screening method, to increase the protection against HPV genotypes, defined high-risk oncogenic genotypes, that are the greater cause, if not the only, of the development of the carcinoma of the uterine cervix.

    Cerca con Google Frazer IH. Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol. Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. Nuclear localization but not PML protein is required for incorporation of the papillomavirus minor capsid protein L2 into virus-like particles.

    Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. Human Papillomavirus.

    Tumore della cervice uterina | Fondazione Umberto Veronesi

    IARC Monographs on the evaluation of carcinogenic risk to humans. Lyon ; vol International Agency for Research on Cancer. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis Ann Oncol.

    High-risk HPV type-specific clearance rates in cervical screening. Br J Cancer. Human papillomavirus and cervical cancer. HPV in the etiology of human cancer.

    Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. Cofactors in human papillomavirus carcinogenesis role of parity, oral contraceptives, and tobacco smoking.

    J Natl Cancer Inst Monogr. Cancer Res. Cerca con Google Palefsky J. Human papillomavirus infection in HIV-infected persons.

    La neoplasia della cervice uterina

    Top HIV Med. Eur J Cancer. Genital tract infections, cervical inflammation, and antioxidant nutrients assessing their roles as human papillomavirus cofactors.

    Extralesional detection and load of human papillomavirus DNA: a possible marker of preclinical tumor spread in cervical cancer. J Low Genit Tract Dis. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

    J Pathol. The burden of HPV-related cancers. HPV and Cervical Cancer in the wored. HPV type-distribution in women with and without cervical neoplastic diseases. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Globocan incidence, mortality and prevalence worldwide. The Bethesda System: terminology for reporting results of cervical cytology.

    Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions. Cancer Epidemiol Biomarkers Prev. Cerca con Google Koss Leopold G. Cerca con Google Hubbard RA. Human papillomavirus testing methods. Arch Pathol Lab Med.

    Molecular diagnosis of human papillomavirus HPV infections. J Clin Virol. Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible. J Clin Microbiol. Cerca con Google Manos, M. Wright, A. Lewis, T. Broker, and S. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses.

    Cancer Cells ; 7: Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses.

    Am J Pathol. Human papillomavirus technologies. Clinical role of p16INK4a expression in liquid-based cervical cytology: correlation with HPV testing and histologic diagnosis. Am J Clin Pathol. Use of pINK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial. Lancet Oncol. Cerca con Google Stanley MA. Human papillomavirus vaccines.

    Rev Med Virol. Cerca con Google Stanley M.